Telix Pharmaceuticals Limited: Raphaël Ortiz Joins Teli

MELBOURNE, Australia and LIÈGE Belgium, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that Raphaël Ortiz has joined the Company as Chief

Related Keywords

Australia , Melbourne , Victoria , United States , Canada , America , Australian , Stewart Holmstrom , Telix Rapha , Richard Valeix , Unitedstatesandmaynotbeofferedorsoldwithintheunited States , Christian Behrenbruch , Telix Pharmaceuticals , Twitter , Novartis Company , Drug Administration , Australian Therapeutic Goods Administration , Corporate Communications , Telix Pharmaceuticals Limited , Pharmaceuticals Limited , Chief Operating Officer , Europe Middle East , Latin America , Advanced Accelerator Applications , Asia Pacific Cluster Head , Molecularly Targeted Radiationand , Managing Director , Chief Executive , Telix , Pharmaceuticals , Imited , Apha 235 L , Ortiz , Coins , Chief , Operating , Officer , Mea ,